Department of Urology, National University Hospital, Singapore.
Division of Urology, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Università Politecnica delle Marche, Ancona, Italy.
Neurourol Urodyn. 2021 Aug;40(6):1389-1401. doi: 10.1002/nau.24708. Epub 2021 May 26.
To evaluate outcomes after benign prostate hyperplasia (BPH) surgery among men with lower urinary tract symptoms (LUTS) only versus those with urinary retention (UR).
The protocol was registered in PROSPERO with ID#232253. Eligible studies identified from four electronic databases. Search, data extraction and quality assessment were performed independently by two reviewers. Studies with perioperative, functional, early and late complication outcomes included.
Twenty-five studies, 14 593 patients including 1 randomized controlled trial, 11 prospective and 13 retrospective studies included for meta-analysis. This showed higher risk of immediate transient recatherization (risk ratio [RR]: 5.29, p < 0.00001), longer days to trial-off-catheter (mean difference [MD]: 0.25, p < 0.00001), longer hospitalization stay in the UR group (MD: 0.35, p < 0.00001), and higher risk of intraoperative blood transfusions (RR: 1.90, p = 0.002), postoperative urinary tract infections (RR: 1.49, p < 0.00001) and sepsis (RR: 8.15, p = 0.009) too. Failure of surgery like permanent recatheterization (RR: 5.27, p < 0.00001) was more in preoperative UR group. Negligible differences seen in long term functional outcomes between the two groups (International Prostate Symptom Score at 12 months, MD: -0.06, p = 0.68; Quality of Life at 12 months, MD: 0.20, p < 0.00001; maximum urinary flow rate at 12 months, MD: -0.33, p = 0.10; and postvoid residual volume at 12 months, MD: 4.32, p < 0.00001).
Preoperative UR patients undergoing surgery for BPH have higher risk of postoperative complications versus LUTS only group including the need for permanent catheterization. Both groups had similar long-term functional outcomes. We could infer that patients with UR on whom surgery is successful, with time may recover bladder function akin to patients with LUTS alone.
评估仅患有下尿路症状(LUTS)的良性前列腺增生(BPH)男性与患有尿潴留(UR)的男性相比,手术后的结果。
该方案已在 PROSPERO 中注册,编号为 232253。从四个电子数据库中确定了符合条件的研究。由两名评审员独立进行检索、数据提取和质量评估。纳入了围手术期、功能、早期和晚期并发症结果的研究。
共有 25 项研究,14593 名患者纳入荟萃分析,其中包括 1 项随机对照试验、11 项前瞻性研究和 13 项回顾性研究。结果显示,UR 组有更高的即刻短暂再导尿风险(风险比 [RR]:5.29,p<0.00001)、试验性拔除导尿管的时间更长(平均差值 [MD]:0.25,p<0.00001)、住院时间更长(MD:0.35,p<0.00001),术中输血风险更高(RR:1.90,p=0.002)、术后尿路感染风险更高(RR:1.49,p<0.00001)和脓毒症风险更高(RR:8.15,p=0.009)。术前 UR 组的手术失败率更高,如永久性再导尿(RR:5.27,p<0.00001)。两组在长期功能结局方面差异无统计学意义(12 个月时国际前列腺症状评分,MD:-0.06,p=0.68;12 个月时生活质量,MD:0.20,p<0.00001;12 个月时最大尿流率,MD:-0.33,p=0.10;12 个月时残余尿量,MD:4.32,p<0.00001)。
与仅患有 LUTS 的患者相比,接受 BPH 手术的术前 UR 患者术后并发症风险更高,包括永久性导尿的需要。两组的长期功能结局相似。我们可以推断,UR 成功手术的患者随着时间的推移可能会恢复膀胱功能,与仅患有 LUTS 的患者相似。